Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 3/20 | 0.38 |
| ▸ | PARP1 | P09874 | 3/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | IL4I1 | Q96RQ9 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL907302 | 0.87 | KMT2A (0.41) | DAOTBXAS1IDH1KDM4EMEN1 | |
| SCHEMBL1133158 | 0.84 | DAO (0.34) | DAOTBXAS1TGM2KDM4EMEN1 | |
| SCHEMBL3677368 | 0.84 | XIAP (0.42) | DAOMEN1KMT2A | |
| SCHEMBL1133470 | 0.80 | TGM2 (0.33) | DAOPARP1TGM2 | |
| SCHEMBL1133219 | 0.80 | ESR1 (0.34) | DAOTGM2 | |
| SCHEMBL1133697 | 0.78 | ELANE (0.33) | DAOPARP1 | |
| SCHEMBL1132986 | 0.77 | GSK3B (0.38) | DAOKDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1133477 | 0.76 | DAO (0.34) | DAOKDM4E | |
| SCHEMBL27794707 | 0.74 | MAOA (0.42) | DAOPKMSMN1; SMN2 | |
| SCHEMBL3674394 | 0.71 | DAO (0.36) | DAOMEN1PKMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4559967-B1 | RUBBER MIXTURES CONTAINING AT LEAST ONE PROCESS AID OF FORMULA (I) | LANXESS DEUTSCHLAND GMBH (DE) | 2026-05-06 | — | — | EP | claimed |
| WO-2025108885-A1 | RUBBER MIXTURES CONTAINING AT LEAST ONE PROCESSING AID OF FORMULA (I) | LANXESS DEUTSCHLAND GMBH (DE) | 2025-05-30 | — | — | WO | claimed |
| EP-4559967-A1 | RUBBER MIXTURES CONTAINING AT LEAST ONE PROCESS AID OF FORMULA (I) | LANXESS Deutschland GmbH (DE) | 2025-05-28 | — | — | EP | claimed |
| WO-2025034218-A1 | BETA RADIATION-RESISTANT ELASTOMERIC COMPOSITIONS, ARTICLES, AND METHODS THEREOF | BARD PERIPHERAL VASCULAR, INC. (US) | 2025-02-13 | — | — | WO | claimed |
| US-20240209192-A1 | RUBBER COMPOSITION, RUBBER-METAL COMPOSITE, TIRE, HOSE, AND CRAWLER | BRIDGESTONE CORPORATION (JP) | 2024-06-27 | — | — | US | claimed |
| US-20240191060-A1 | RUBBER MIXTURES CONTAINING N,N'-DIALKYL-P-PHENYLENEDIAMINES | LANXESS DEUTSCHLAND GMBH (DE) | 2024-06-13 | — | — | US | claimed |
| US-20240174802-A1 | Build UP Film Curable Compositions | AGC MULTI MAT AMERICA INC (US) | 2024-05-30 | — | — | US | claimed |
| US-20240174623-A1 | Build UP Film Curable Compositions | AGC Multi Material America, Inc. | 2024-05-30 | — | — | US | claimed |
| EP-4321349-A1 | RUBBER COMPOSITION, RUBBER-METAL COMPOSITE, TIRE, HOSE, AND CRAWLER | BRIDGESTONE CORPORATION (JP) | 2024-02-14 | — | — | EP | claimed |
| EP-4313622-A1 | RUBBER MIXTURES CONTAINING N,N?-DIALKYL-P-PHENYLENEDIAMINES | LANXESS Deutschland GmbH (DE) | 2024-02-07 | — | — | EP | claimed |
| US-6581660-B2 | Antireversion agents of 1,3-bis(citraconimidomethyl)benzene and hexamethylene 1,6-bis(thiosulfate), disodium salt, dihydrate | THE GOODYEAR TIRE & RUBBER COMPANY | 2003-06-24 | — | — | US | claimed |
| US-20030015271-A1 | Tire with rubber tread of cap/base construction wherein the tread base rubber composition contains combination of anti-reversion agents | THE GOODYEAR TIRE & RUBBER COMPANY | 2003-01-23 | — | — | US | claimed |
| US-20020173577-A1 | Heat resistance at high speed | DEEVERS SUSAN LYNN (US) | 2002-11-21 | — | — | US | claimed |
| EP-1241213-A2 | Tire with tread of rubber composition which contains 1,3-bis-(citraconimidomethyl) benzene or pentaerythritol triacrylate | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2002-09-18 | — | — | EP | claimed |
| US-20020088521-A1 | Rubber composition for breaker cushion | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2002-07-11 | — | — | US | claimed |
| EP-1211282-A1 | Rubber mix comprising expanded layer silicates | ConiTech Holding GmbH (DE) | 2002-06-05 | — | — | EP | claimed |
| EP-1207054-A1 | Rubber composition for breaker cushion | SUMITOMO RUBBER INDUSTRIES LIMITED (JP) | 2002-05-22 | — | — | EP | claimed |
| EP-1197518-A1 | RUBBER COMPOSITION AND PNEUMATIC TIRE MADE WITH THE SAME | BRIDGESTONE CORPORATION (JP) | 2002-04-17 | — | — | EP | claimed |
| EP-0988999-A2 | Antireversion agent for inserts used in runflat tires | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2000-03-29 | — | — | EP | claimed |
| US-5623007-A | CONTAINING ANTIREVERSION AGENT COMPRISING ZINC SALTS OF CARBOXYLIC ACIDS AND A BIS-CITRACONIMIDO COMPOUND | KUMHO TIRE CO., LTD. (KR) | 1997-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174623-A1 | Build UP Film Curable Compositions | CBX7, CBX4, CBX2 | DAO 1560/4885PARP1 498/4885CYP19A1 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.